Related Experiment Video
Updated: Dec 26, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Fibrosis and cancer: A strained relationship
Bram Piersma1, Mary-Kate Hayward2, Valerie M Weaver3
1Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco (UCSF), USA; Matrix research group, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, the Netherlands.
Tumor fibrosis stiffens the extracellular matrix (ECM), promoting cancer growth and spread. Targeting this fibrosis offers a new strategy to combat aggressive cancers.
Area of Science:
- Oncology
- Biomedical Engineering
- Cancer Biology
Background:
- Tumors develop through extracellular matrix (ECM) deposition, remodeling, and cross-linking, leading to fibrosis and stromal stiffening.
- This stiffened tumor stroma enhances cancer cell growth, survival, migration, and mesenchymal transition, while also promoting angiogenesis, hypoxia, and immune suppression.
- Increased tissue fibrosis and stromal stiffness correlate with tumor aggression and poor patient prognosis.
Purpose of the Study:
- To review the reciprocal interactions between tumor cells, cancer-associated fibroblasts (CAFs), immune cells, and ECM stiffness in cancer development and progression.
- To explore CAF heterogeneity and its role in fibrotic stroma engineering, tumor cell mechanotransduction, and immune modulation.
- To discuss emerging anti-fibrotic therapies for cancer treatment.
Main Methods:
- Literature review focusing on the interplay between cancer cells, CAFs, immune cells, and ECM stiffness.
- Analysis of data from breast cancer and pancreatic ductal carcinoma (PDAC) studies to illustrate mechanoreciprocity in tumor evolution.
- Discussion of emerging anti-fibrotic strategies.
Main Results:
- Fibrosis and stromal stiffness are key drivers of tumor malignancy, enhancing tumor cell proliferation, survival, migration, and immune evasion.
- Cancer-associated fibroblasts (CAFs) play a critical role in engineering the fibrotic tumor microenvironment, influencing tumor cell mechanics and immune responses.
- Mechanoreciprocity between tumor cells and the ECM is central to tumor evolution, as evidenced in breast cancer and PDAC.
Conclusions:
- Stromal stiffness and fibrosis are critical determinants of cancer aggression and patient outcomes.
- Targeting the interplay between CAFs, ECM, and tumor cells, particularly through anti-fibrotic strategies, holds promise for novel cancer therapies.
Related Concept Videos
Introduction to Fibroblasts
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
The Tumor Microenvironment
Cancer Prevention
Some...
Psychoneuroimmunology: Diabetes and Cancer

